UBS Group’s Sharps Compliance Corp SMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,138
| Closed | -$6K | – | 11728 |
|
|
2022
Q2 | $6K | Sell |
2,138
-600
| -22% | -$2.5K | ﹤0.01% | 8815 |
|
|
2022
Q1 | $16K | Sell |
2,738
-13,025
| -83% | -$81.8K | ﹤0.01% | 7801 |
|
|
2021
Q4 | $113K | Buy |
15,763
+13,457
| +584% | +$103K | ﹤0.01% | 6205 |
|
|
2021
Q3 | $19K | Buy |
2,306
+1,842
| +397% | +$17.1K | ﹤0.01% | 7259 |
|
|
2021
Q2 | $5K | Sell |
464
-1,156
| -71% | -$16.1K | ﹤0.01% | 8621 |
|
|
2021
Q1 | $23K | Sell |
1,620
-3,311
| -67% | -$42.6K | ﹤0.01% | 7267 |
|
|
2020
Q4 | $47K | Buy |
4,931
+4,439
| +902% | +$33.9K | ﹤0.01% | 6250 |
|
|
2020
Q3 | $3K | Sell |
492
-93,023
| -99% | -$677K | ﹤0.01% | 7598 |
|
|
2020
Q2 | $658K | Buy |
+93,515
| New | +$665K | ﹤0.01% | 3912 |
|
|
2020
Q1 | – | Sell |
-1,000
| Closed | -$4K | – | 8606 |
|
|
2019
Q4 | $4K | Sell |
1,000
-69
| -6% | -$296 | ﹤0.01% | 7699 |
|
|
2019
Q3 | $4K | Sell |
1,069
-4,105
| -79% | -$15.5K | ﹤0.01% | 7588 |
|
|
2019
Q2 | $19K | Buy |
5,174
+2,629
| +103% | +$9.1K | ﹤0.01% | 6664 |
|
|
2019
Q1 | $10K | Sell |
2,545
-9,060
| -78% | -$32.9K | ﹤0.01% | 6840 |
|
|
2018
Q4 | $40K | Buy |
11,605
+10,605
| +1,061% | +$36.5K | ﹤0.01% | 6291 |
|
|
2018
Q3 | $3K | Sell |
1,000
-2,755
| -73% | -$9.7K | ﹤0.01% | 7688 |
|
|
2018
Q2 | $14K | Buy |
3,755
+2,505
| +200% | +$9.88K | ﹤0.01% | 6957 |
|
|
2018
Q1 | $6K | Sell |
1,250
-433
| -26% | -$1.94K | ﹤0.01% | 7180 |
|
|
2017
Q4 | $7K | Sell |
1,683
-4,379
| -72% | -$18.4K | ﹤0.01% | 7259 |
|
|
2017
Q3 | $29K | Buy |
6,062
+943
| +18% | +$4.53K | ﹤0.01% | 6191 |
|
|
2017
Q2 | $21K | Sell |
5,119
-1,731
| -25% | -$7.39K | ﹤0.01% | 6273 |
|
|
2017
Q1 | $33K | Sell |
6,850
-4,198
| -38% | -$19.3K | ﹤0.01% | 5796 |
|
|
2016
Q4 | $42K | Buy |
11,048
+4,198
| +61% | +$17K | ﹤0.01% | 5967 |
|
|
2016
Q3 | $30K | Hold |
6,850
| – | – | ﹤0.01% | 5944 |
|
|
2016
Q2 | $30K | Hold |
6,850
| – | – | ﹤0.01% | 5944 |
|
|
2016
Q1 | $38K | Hold |
6,850
| – | – | ﹤0.01% | 5707 |
|
|
2015
Q4 | $60K | Sell |
6,850
-250
| -4% | -$2.17K | ﹤0.01% | 5668 |
|
|
2015
Q3 | $62K | Sell |
7,100
-1,703
| -19% | -$12.3K | ﹤0.01% | 5640 |
|
|
2015
Q2 | $61K | Buy |
8,803
+1,203
| +16% | +$7.53K | ﹤0.01% | 5836 |
|
|
2015
Q1 | $48K | Sell |
7,600
-3,067
| -29% | -$15.5K | ﹤0.01% | 6097 |
|
|
2014
Q4 | $45K | Buy |
+10,667
| New | +$47.4K | ﹤0.01% | 6625 |
|
UBS Group's SMED Position: Q3 2022 in Review
UBS Group sold out of Sharps Compliance Corp (SMED) in Q3 2022, closing a stake of 2,138 shares — an estimated $6K sold.
UBS Group first reported a position in SMED in Q4 2014 and held it in 30 quarters. The position peaked at $658K in Q2 2020. 0 funds tracked by Wall St. Rank hold SMED as of Q3 2022.
- UBS Group reported no remaining Sharps Compliance Corp position as of Q3 2022 after selling out during the quarter.
- UBS Group sold 2,138 Sharps Compliance Corp shares in Q3 2022, an estimated $6K.
- UBS Group first reported a position in Sharps Compliance Corp in Q4 2014 and held it in 30 quarters.
- UBS Group's Sharps Compliance Corp position peaked at $658K in Q2 2020.
- 0 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q3 2022.
Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.